Study Explores Racial/Ethnic Disparities in Incidence of Breast Cancer Subtypes
May 16th 2014An analysis of a large, nationwide dataset has revealed that regardless of their socioeconomic status, black women are nearly twice as likely to be diagnosed with triple-negative breast cancer (TNBC) and Asian/Pacific Islander women are more likely to be diagnosed with HER2-overexpressing breast cancer compared with white women.
New DNA Stool Test Offers Higher Sensitivity Screening
May 16th 2014A noninvasive stool DNA test may be a new option to increase rates of colorectal cancer screening, proving more sensitive in identifying colon cancer, advanced precancerous lesions, and polyps than currently available fecal immunochemical testing (FIT).
Nivolumab Delivers Durable Remissions With Low Toxicity in Advanced Melanoma
May 14th 2014Nivolumab, a PD-1-specific antibody, has been shown to produce long-term remissions with limited toxicity in patients with advanced melanoma, according to results from one of the longest follow ups to examine the drug
New Resources on Managing Obesity-Related Challenges of Cancer Patients for Providers, Patients
May 13th 2014The American Society of Clinical Oncology has released new resources to help healthcare providers and patients manage the complications of obesity in patients with cancer, the organization announced.
Orientation Eases Stress and Helps Breast Cancer Patients Manage Neoadjuvant Regimens
May 8th 2014Nurses at the Rutgers Cancer Institute of New Jersey have developed a program to help patients with early-stage breast cancer to better understand and retain information about their presurgical treatments.
FDA Approves Home Administration of Omacetaxine Mepesuccinate for CML
May 6th 2014A home administration route for the subcutaneous injection omacetaxine mepesuccinate (Synribo) was approved by the FDA for use in patients with chronic or accelerated phase chronic myeloid leukemia (CML) who are resistant or intolerant to treatment with tyrosine kinase inhibitors.
Shared Decision Making, Perceived Control Improves Patient Satisfaction During Radiation Therapy
April 23rd 2014Cancer patients felt more satisfied with their radiation treatment when they remained active in treatment decisions, according to a study conducted by researchers from the Perelman School of Medicine at the University of Pennsylvania.
Ramucirumab Approved for Advanced Stomach Cancer
April 22nd 2014The FDA has approved ramucirumab (Cyramza) as a single-agent treatment for patients with unresectable or metastatic gastric cancer or gastroesophageal junction (GEJ) adenocarcinoma following fluoropyrimidine- or platinum-containing therapy.